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Glycosyl albumin and diabetic microalbuminuria: Demonstration of
altered renal handling. In attempt to elucidate the link between the
nonenzymatic glycosylation of proteins and the diabetic functional
nephropathy, renal handling of glycosyl albumin has been evaluated in
15 normal subjects and 29 insulin-dependent diabetic patients divided in
three groups according to their urinary excretion rates of albumin
(Ub): (group A) ten diabetic patients with Ualb < 10 gIm', (group B)
12 patients with Ualb between 10 and 100 g/m', and (group C) seven
patients with Ualb > 100 gIm'. Albumin was purified with Blue-
Sepharose CL-6B. The carbohydrate bound to albumin was determined
chemically with thiobarbituric acid after the acid hydrolysis of the
protein. Serum glycosyl albumin concentration in normal subjects was
0.1256 0,009 nmoles of hydroxymethylfurfural per nanomole of
albumin, in group A, 0.1900 0.0124; in group B, 0.2199 0.0177; and
in group C, 0.2224 0.0273. Urinary glycosyl albumin concentration
was 1.8467 + 0.2132 in normal subjects, 1.4369 0.3355 in group A,
1.008 0. 1584 in group B, and 0.2614 + 0.0295 in group C. In normal
subjects and patients without apparent nephropathy (groups A and B),
the clearance of albumin correlated with the serum concentration of
glycosyl albumin. In all patients (groups A, B, and C) the urinary-serum
glycosyl albumin concentration ratio was correlated inversely with
albumin clearance. These data show that in normal subjects and
diabetic patients with normal excretion rates of albumin and microalbu-
minuric diabetic patients the passage of glycosyl albumin through the
glomerular wall is facilitated in contrast to normal albumin and that
glycosyl albumin plays an important role in the pathogenesis of diabetic
functional nephropathy.
Albumine glycosylée et microalbuminurie diabétique: Demonstration
d'une anomalie de l'excrétion renale. Dans une tentative d'élucider La
liaison entre Ia glycosylation nonenzymatique des protéines et La
nephropathie fonctionnelle diabdtique, l'excrdtion rénale d'albumine
glycosylée a été évaluCe chez 15 sujets normaux et 29 malades
diabCtiques insulino-dépendants, divisds en trois groupes selon leur
excretion urinaire d'albumine (Ulb): (groupe A) dix malades diabéti-
ques avec UaIblO < g/m', (groupe B) 12 malades avec UaIb entre 10 et
100 tgIm', et (groupe C) sept malades avec UaIb > 100 g/m'.
L'albumine a étd purifiée sur Blue-Sepharose CL-6B. Les hydrates de
carbone lies a l'albumine ont été déterminés chimiquement avec de
l'acide thiobarbiturique après hydrolyse acide des protéines. La con-
centration sérique d'albumine glycosyLee chez les sujets normaux était
de 0,1256 0,009 nmoles d'hydroxymethylfurfural par nanomoles
d'albumine, dans le groupe A, de 0,1900 0,0124; dans le groupe B,
0,2199 0,0177; et dans le groupe C, de 0,2224 0,0273. La
concentration urinaire d'albumine glycosylde dtait de 1,8467 0,2132
chez les sujets normaux, 1,4369 0,3355 dans le groupe A, 1,008
0,1584 dans le groupe B, et 0,2614 0,0295 dans le groupe C. Chez les
sujets normaux et les malades sans ndphropathie apparente (groupes A
et B), Ia clearance de l'albumine Ctait corréLée avec Ia concentration
senque d'albumine glycosylée. Chez tous les malades (groupes A, B, et
C), le rapport des concentrations urinaires et sériques d'albumine
gLycosylee Ctait inversement corrélé avec Ia clearance de l'albumine.
Ces données indiquent que chez les sujets normaux et Les malades
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diabCtiques avec des debits d'excretion d'albumine normaux, et chez
des diabetiques microalbuminuriques, le passage d'albumine glycosylCe
a travers la paroi glomerulaire est facilité par rapport a l'albumine
normale, et l'albumine glycosylee joue un role important dans la
pathogenic de la nCphropathie fonctionnelle diabetique.
An increasing body of evidence points to nonenzymatic
glycosylation of serum and structural proteins {1—3], including
albumin [4, 5], as the major factor that accounts for the long-
term complications of diabetes mellitus.
The comparative dearth of information concerning the effects
of glycosylation on the structure and functions of specific
proteins has been lessened recently by the finding [6] of an
increase of isoelectric point (p1) of albumin created by the
condensation of glucose on its amino groups (Fig. 1).
As is well known, the electrical charge is a factor quite
relevant to filtration through the glomerular wall of macromol-
ecules [7, 8] as well as to their tubular reabsorption [9].
Clearance studies showed that positively charged albumin that
easily crosses the blood-brain barrier [10] are also freely
excreted into urine as well [11]. Therefore, an important role of
albumin glycosylation in the pathophysiology of the microalbu-
minuria preceding the onset of diabetic nephropathy [12] can be
reasonably surmised.
The aim of the present study was to investigate the renal
handling of glycosyl albumin (GA) in normal subjects and
diabetic patients with various degrees of renal involvement as
defined by the excretion rates of albumin (UaIb).
Methods
Patients. Fifteen normal control subjects (five males, ten
females), ranging in age from 21 to 52 years (mean, 33.9), and 29
insulin-dependent diabetic patients [13] (15 males, 14 females),
ranging in age between 6 and 60 years (mean, 42.6) were
studied. All normal subjects were healthy and normotensive
without signs of nephropathy and were not receiving any
medication. Diabetic patients were subdivided according to
their urinary excretion rates of albumin (Ualb) in three groups:
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Fig. 1. Ulirathin isoelectric focusing of albumin subunits from Con-A.
Albumin without affinity for the lectin (A) was washed out with 0.02 M
Tris-HCI, 0.5 M NaCI pH 7.4. Albumin bound to Con-A (B) was eluted
with 0.8 M a-D-glucopyranosid in the starting buffer. Isoelectric focus-
ing was carried out in a silanized glass plate at a contant 10°C in a range
of Ampholines between 3.5 and 9 (pH).
group A, ten patients with UaIb < 10 g/m'; group B, 12 patients
with Ualb between 10 and 100 .tg/m'; and group C, seven
patients with UaIb > 100 gImin [12]. Only urine without signs
of bacteriuria was examined. All patients of groups A and B
were normotensive, whereas four patients of group C had been
previously hypertensive and were receiving a medical treatment
with diuretics and beta-blockers which kept their pressure
values in a normal range. No patients of groups A and B showed
retinopathy. Nephropathy was assumed of diabetic origin if
proteinuria occurred in a patient with a history of diabetes for
more than 10 years, retinopathy, and no history of other renal
disease. Biopsy had not been performed. All patients were
treated with insulin therapy twice daily. Clinical details are
given in Table 1. Informed consents were obtained from all
subjects.
Study protocol. Twenty-four hour urine collections were
performed at home, during a period of normal physical activity
using thimol as a preservative. Urine samples were analyzed for
volume and glucose and then kept at —20°C for not more than 1
month. Sera were obtained from normal subjects and diabetic
patients in the morning after an overnight fast, centrifugated at
x3000g for 30 mm, tested for glucose, and then stored at —20°C
for less than 1 month until glycosyl albumin was performed.
Purification of albumin. Albumin was purified from other
serum and urinary protein by affinity chromatography with a 1.5
x 7 cm column of Blue-Sepharose CL-6B (Pharmacia, Uppsa-
Ia, Sweden) [14, 15] previously regenerated according to the
supplier's instructions. After washing out other proteins by 0.05
M Tris-HC1, 0.1 M KC1 pH 7 buffer, albumin was eluted by 0.05
M Tris-HC1, 1.5 M KC1 pH 7 buffer, dialyzed and ultrafIltrated
(Amicon UM-lO membranes) to reach an adequate protein
concentration. Albumin purity was tested by bidimensional
immunoelectrophoresis in which the first dimension was repre-
sented by a conventional SDS-polyacrylamide gel and the
second by an agarose gel containing anti-albumin antibody [161.
Total glycosyl albumin assay. For the assay of GA, 3 ml of
protein solution were mixed in triplicate with 0.45 ml of glacial
acetic acid and kept at 98°C for 24 hr. After cooling, 0.3 ml 40%
(w/v) of fresh trichloracetic acid was added to the solution and
centrifugated at x 3000g for 15 mm. Thiobarbituric acid (0.5 ml
0.05 M, Merck, Darmstadt, West Germany) was then added to 1
ml supernatant incubated at 40°C for 30 mm, and extinction at
443 m was measured [17, 18]. For all determinations three
standard hydroxymethylfurfural (HMF) (Merck) solutions and
three blank samples were prepared. Albumin concentration
before hydrolysis was performed in triplicate by the Coomassie
dye binding assay of Bradford [19] as modified by Read and
Northcote [201 using crystallized human serum albumin (Beher-
ingwerke, Marburg, West Germany) as the standard. The mean
coefficient of variation (CV) for the within-assay precision,
tested by measuring GA concentration of the same serum pool
at three different concentrations was 4%. The mean between
assay reproducibility, calculated on the basis of five different
determinations of the same poo1, was 3.6%. GA concentration
is given as nanomoles of HMF per nanomole of albumin [17].
GA clearance was calculated applying the formula
U.V
P
corrected to 1.73 m2 body surface area, where U and P were the
products between GA concentration and the amount of albumin
in 1 ml respectively of urine and serum.
Characterization of cationic glycosyl albumin. A pooled
sample of purified serum albumin from diabetic patients was
applied to a 1 x 2 cm column of Concanavalin A-Sepharose
(Con A) (Pharmacia) and chromatography performed as de-
scribed [6]. Fractions A and B from Con A, after dialysis, were
ultrafiltrated and submitted to isoelectric-focusing (IEF). Ul-
trathin IEF was carried out in polyacrylamide slab gel (T = 7%,
C = 4%) precoated in silanized glass plate at a constant 10°C
using a LKB Multiphor System. The polymerization solutions
contained 2.5% (wlv) carrier Ampholytes (LKB, Bromma,
Sweden) with a linear gradient of pH from 3.5 to 9 and 12%
(wlv) glycerol. Isoelectric points were measured using a LKB
glass electrode 2117-111 at a constant 10°C. Fixing, staining,
and destaining were performed as decribed [21].
Other methods. Total urinary protein excretion was evaluat-
ed in triplicate with Coomassie Blue dye binding [19, 20] using
crystallized human serum albumin as the standard. Serum and
urinary albumin and immunoglobulin G were quantitated by
nephelometry (Beckman Instruments Inc., Fullerton, Califor-
nia) [22]. f32-microglobulin was evaluated by a radio-
immunoassay (Pharmacia) [23]. Creatinine was determined by
Jaffe reaction [241 and glucose by the oxidase-peroxidase sys-
tem. For all spectrophotometric analysis a Beckman 42 Model
was used. Excretion rates of total albumin were derived from
concentration and timed urine. Clearances were calculated
from urinary and serum concentrations applying the formula
.!J.X and corrected to 1.73 m2 body surface area.
Statistical method. Data from control and diabetic groups
were compared using the one-way analysis of variance. The
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Table 1. Clinical data of 15 normal subjects and 29 insulin-dependent diabetic patients. Diabetic patients were subdivided in three groups
according to their urinary excretion rates of albumina
N Sex
Age
years
Ideal weight
%
.Duration of
diabetes
years
Retinopathy
no.
Blood glucose
Fasting Postprandial
nmoles/!iter
Normal subjects 15 M 5
F 10
33.9 96.2 — — 4.6 6.3
Group A
Ua,b<lOJsgImin
10 M 4F 6 37.4 103.4 5.5 0 11.09 11.6
Group B
(ia/b < 100 /ig/min
12 M 7F 5 44.6 100.7 5.34 0 9.95 11.1
Group C
(ia/b> 100 g/min
7 M 3F 4 51.4 4 mild3 prolif 6 10.2
a Data are expressed as mean SEM.
Table 2. Renal function and urinary excretion rates of total protein, albumin, IgG, and /32-microglobulin in 15 normal subjects and 29 diabetic
patients'
N
Urinary
flow
mI/mm
Urinary
glucose
excretion
g/24 hr
Urinary
total
protein
excretion
Urinary
albumin
excretion
Urinary
IgG
excretion
Urinary /32-
microglobulin
excretion
ng/min
Albumin clearance
ml/min/1.73 m2 io
Creatinine
clearance
ml/min/I.73 m2/sg/min
Normal
subjects
(15) 0.72
(0.43—1.2)
0.04
(0.02—0.05)
46.45
(31.6—63.5)
4.7
(2.1—6.9)
2.5
(0.9—3.3)
71.2
(10.5—98.2)
1.02
(0.7—1.8)
107.6
Group A (10) 0.91
(0.75—1.32)
19.4
(8.3—38.2)
48.94
(30—70.5)
4.9
(3.5—8)
2.63
(1.3—5.4)
60.2
(15.2—100.1)
1.01
(0.8—1.3)
104.3
Group B (12) 1.07
(0.86—2.52)
19.38
(6.5—29.6)
97.13
(60.1—282.3)
32.6
(10.7—100)
8.84
(2—9.3)
76.5
(25.2—103)
7.48
(2.5—28.3)
116.8
Group C (7) 0.8
(0.63—1.1)
0.23
(0.1—0.42)
1465.07
(363—3700)
856.5
(211—2688)
121.5
(40—260)
1595.3
(496—4430)
249.28
(43.7—591.8)
41.2b
15.9
a Values are given as mean and range of variation (in parentheses).
b p < 0.001 in contrast with groups A, B, and C.
least square method was used for the calculation of the correla-
tion coefficient [25].
Results
Characterization of GA with altered p1. The chromatography
on Con A resolves albumin in two subunits with a different
amount of carbohydrates: fraction A without affinity for the
lectin and a low content of carbohydrates and fraction B which
binds to Con A and has a high content of carbohydrates [6].
Isoelectric-focusing of the albumin subunit with a high content
of carbohydrates (fraction B) (Fig. 1) shows an augmented
microheterogeneity with many cationic bands focused from 5 to
9(pH).
Urinary protein composition. Table 2 summarizes the renal
function and the urinary excretion rates of total protein, albu-
min, immunoglobulin G (IgG), and /32-microglobulin in normal
subjects and diabetic patients. Group B patients show augment-
ed excretion rates of albumin and IgG but exhibit normal /32-
microglobulin excretion rates if compared to normal subjects
and group A patients. These findings are consistent with a
glomerular proteinuria of functional characteristics [26]. Group
C patients show markedly increased excretion rates of heavy
proteins such as albumin and IgG and small proteins such as /32-
microglobulin. This pattern is also consistent with a glomerular
type of proteinuria [26].
Renal handling of GA. The determination of ketoamine
derivatives of proteins by HMF assay is so far a widely
accepted method used to evaluate the concentration of glyco-
proteins in biological fluids [271. The amount of HMF released
after the acid hydrolysis of a protein should allow the calcula-
tion of the percentage of the total protein which has been
glycosylated, assuming a stechiometric relationship between
carbohydrate and protein of 1:1. Unfortunately, for albumin,
the inconstant amount of the carbohydrate bound to the pro-
tein, as shown from the reported occurrence of GA subunits
with a different content of HMF [6], prevent a direct evaluation
of the exact percentage of GA. The values of GA concentration
refer to the mean amount of carbohydrate bound to 1 mole of
albumin.
Serum concentration of GA is 0.1256 0.009 nmoles/ml
(range, 0.0698 to 0.1829) in normal subjects and 0.2101 0.0107
(range, 0.1073 to 0.3007) in all diabetic patients (P < 0.005). The
detailed values for every group are reported in Table 3. Urinary
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Table 3. Serum and urinary glycosyl albumin (GA) concentration and clearance in 15 normal subjects and 29 diabetic patientsa
N
Serum GA concentration
nmoles HMF
Urinary GA concentration
nmoles HMF
Clearance GA
mllmin/1.73 in2 x I0nmoles albumin nmo!es albumin
Normal subjects (15) 0.1256 1.8467 15.74
Group A (10) 0.1900" 1.4369 6.75
U,,b < 10 g/min
Group B (12) 0.2199c l.008b 35.62
U < 100 g/min 12.64
Group C (7) 0.2224c 0.2614d 222.422d
U,b > 100 /.g/min
Values are mean SEM.
b p < 0.025 in contrast with normal subjects.
P < 0.005 in contrast with normal subjects.
d P < 0.001 in contrast with other groups.
P < 0.005 in contrast with group A.
Albumin clearance
(mI/minhl732 x 10—a)
Discussion
0
Albumin clearance
(mI/mm/i 732 x i0)
V 0.16 + 0.03 In X
r = 0.482
P = 0.01
N = 37
15
10
5
V = 7.3 X°3"
= 0.8426
P < 0.001
N = 29
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Fig. 2. Relationship between serum GA concentration and albumin
clearance in 15 normal subjects (A) and 22 diabetic patients without
apparent nephropathy (•) (UaJb < 100 g/m').
concentration of GA is greatly increased in contrast to its serum
concentration in normal subjects and group A patients (1.8467
0.2272 for normal subjects, 1.4369 0.3355 for group A),
whereas it is increased to a lesser degree in group B patients
(1.1008 0.1584) (P < 0.025 in contrast to normal subjects).
Group C patients show urinary GA concentrations which do not
exceed their serum values (0.2164 0.0295) (P < 0.001 in
contrast with normal and other groups).
Serum concentrations of GA correlate with albumin clear-
ances (Fig. 2) in normal and diabetic subjects without apparent
nephropathy (groups A and B); P < 0.01). In all patient groups
the urinary-serum GA concentration ratio, which is an index of
renal selectivity toward GA, correlates with albumin clearance.
Figure 3 shows the relationship between albumin clearance and
urinary/serum GA concentration which exhibits the best corre-
lation coefficient (r —0.94, P <0.001).
Our results confirm the existence of an increased glycosyla-
tion of serum albumin in diabetes mellitus [4, 17] and provide
, ,i
oc
a
E
Fig. 3. Relationship between albumin clearance and urinary/serum GA
concentration ratio in 29 diabetic patients with various degrees of renal
involvement (groups A, B, and C).
evidence for a consequent formation of cationic subunits of this
protein. This was a rather unexpected finding, since glycosyla-
tion should bring about a decrease rather than an increase in p1
of any protein; therefore, further studies centered on the
molecular mechanism of cationization of GA should be made.
At any rate, the formation of cationic subunits of albumin
induced by its glycosylation can reasonably account, while in
agreement with the current views on topics [7, 8, 10], for the
variation of the permselectivity of the basal membrane toward
GA reported in this paper. The mechanism subserving the
decrease of the preferential excretion of GA in microalbumin-
uric diabetic subjects with increased glycosylation (and cationi-
zation) of serum albumin are still poorly understood. On the
basis of these data, it seems likely that in diabetic patients the
enhanced excretion of GA can clearly but not completely
contribute to the global microalbuminuria and that the de-
creased percentage of urinary GA in these patients has generat-
ed an increase of normal albumin excretion.
Data from other sources confirm our observations: Purtell et
al [11] demonstrate in rats that the injection of heterologous
cationized albumin produces not only an increase in heterolo-
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gous albumin excretion (with higher p1), but also an increased
glomerular permeability to native endogenous albumin. More-
over, as reported by other investigators [28], the ingestion of
GA by the micropinocytic vescicles of endothelial cells is much
greater than that of normal albumin and the presence of GA also
stimulates the ingestion of unmodified albumin. On the contrary
experiments with dextran sulfate have shown that in untreated
diabetic rats with proteinuria there is a limitation to the passage
across the glomerular wall of anionic macromolecules [29].
Therefore, an apparent discrepancy exists between the finding
of a normal clearance of charged dextran and that of an
increased excretion of normal albumin. It should be recalled,
however, that in this as well as in other studies using polysac-
charide macromolecules such as dextran, the variations in
molecular conformation, which are a very relevant factor
affecting the transit of macromolecules across the molecular
wall [7], cannot be controlled to any extent.
A possible role of tubular reabsorption may be eventually
surmised, in so far as it could affect the urinary excretion of
protein through a mechanism which is charge-dependent [9].
Recent renal micropuncture studies show that in normal female
rats about 17 mg of albumin are daily reabsorbed by the tubule
[301; thus, a high proximal tubular concentration of GA may
alter this physiological mechanism. To our knowledge, it is not
possible at present to establish pathophysiological correlation
between the chronic impairment of renal handling of GA and
the development of the late diabetic nephropathy. However,
pseudodiabetic glomerular changes have been produced in mice
by repeated injections of glycosylated proteins [31]; moreover,
as pointed out above, injections of cationized albumin in rats
[11] led to the deposition of albumin in the glomerulus with a
pattern similar to the one described in the membrane of diabetic
humans [32]. A role of hyperfiltration in promoting excessive
mesangial deposition of macromolecules, as the forerunner of
glomerular sclerosis, has been claimed in the pathogenesis of
functional and chronic nephropathy as well [33, 34]. An implica-
tion of GA hyperfiltration in the mesangial deposition of macro-
molecules and widening may be hypothesized and other works
focusing this aspect are needed.
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